MDT250502C81000
- 3.50
- 0.000.00%
Medtronic Newsroom
Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing
J&J-backed HistoSonics Explores Sale at $2.5 Billion Valuation, FT Reports
Image-guided Navigation Market Worth US$3,912.5 Million by 2030 With 9.0% CAGR | MarketsandMarkets
Former Medtronic Exec Rob Ten Hoedt Named Chair at Tricuspid Repair Company Coramaze
Medtronic Education Program Opens Doors for Employees
Medtronic Reinvents Surgical Training for a New Era
Wells Fargo Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $98
Barclays Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $109
Is It Time To Consider Buying Medtronic Plc (NYSE:MDT)?
Medtronic Inks New Distro Agreement for Retia Medical Argos Cardiac Output Monitor
Medtronic's Defibrillation Lead Gains FDA Approval for Use in Right Ventricle
Reported Saturday, Medtronic's Affera Sphere-360 Catheter Demonstrates Safety And Performance Results For Paroxysmal AFib
Medtronic Announces Outcomes From Two Studies in AFib Patients
Express News | Medtronic PLC - to Begin U.S. Pivotal Trial for Sphere-360 Catheter
Medtronic Affera Pulsed Field Ablation Technologies Continue to Demonstrate Promising Evidence for Atrial Fibrillation Patients
Express News | Medtronic PLC - Study Achieves 98.5% Surgical Success Rate
Express News | Medtronic PLC - Submits Hugo Ras System to U.S. FDA
Express News | Medtronic Expand Uro U.S. Clinical Trial Meets Safety and Effectiveness Primary Endpoints for Hugo™ Robotic-Assisted Surgery System
Medtronic Expand URO U.S. Clinical Trial Meets Safety and Effectiveness Primary Endpoints for Hugo Robotic-assisted Surgery System
Headache For MOH With Trump's Flip-Flop On Pharma Tariff